Derek W. Bartlett

3.5k total citations · 1 hit paper
28 papers, 2.7k citations indexed

About

Derek W. Bartlett is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Derek W. Bartlett has authored 28 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Derek W. Bartlett's work include RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Derek W. Bartlett is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Derek W. Bartlett collaborates with scholars based in United States, Switzerland and Germany. Derek W. Bartlett's co-authors include Mark E. Davis, Jeremy D. Heidel, Helen C. Su, Isabel J. Hildebrandt, Wolfgang Weber, Siwen Hu‐Lieskovan, Timothy J. Triche, A. Gilbert, Jianjun Cheng and Beth Hollister and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Chemical Society Reviews and Nucleic Acids Research.

In The Last Decade

Derek W. Bartlett

25 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging

2007 618 citations Derek W. Bartlett, Mark E. Davis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Derek W. Bartlett United States	17	1.9k	706	488	425	276	28	2.7k
Yuan Fan China	14	1.3k 0.7×	874 1.2×	741 1.5×	347 0.8×	126 0.5×	29	2.3k
Jeremy D. Heidel United States	15	3.2k 1.7×	1.2k 1.7×	861 1.8×	658 1.5×	458 1.7×	21	4.1k
Valentina Fogal United States	19	1.8k 1.0×	379 0.5×	377 0.8×	498 1.2×	130 0.5×	21	2.5k
Sam Chen Canada	23	3.9k 2.1×	627 0.9×	715 1.5×	421 1.0×	455 1.6×	33	4.7k
Leaf Huang United States	25	1.2k 0.6×	743 1.1×	691 1.4×	181 0.4×	147 0.5×	45	2.2k
Steven M. Ansell United States	24	3.7k 2.0×	988 1.4×	559 1.1×	387 0.9×	505 1.8×	47	4.9k
Daniel Rosenblum United States	18	1.8k 1.0×	1.1k 1.6×	1.1k 2.4×	273 0.6×	263 1.0×	39	3.3k
Kun Cheng United States	36	2.5k 1.3×	698 1.0×	684 1.4×	453 1.1×	310 1.1×	102	4.4k
Tracy R. Daniels‐Wells United States	26	1.5k 0.8×	644 0.9×	454 0.9×	187 0.4×	190 0.7×	51	3.0k
Bo Hu China	20	1.8k 1.0×	248 0.4×	394 0.8×	363 0.9×	225 0.8×	88	2.6k

Countries citing papers authored by Derek W. Bartlett

Since Specialization

Citations

This map shows the geographic impact of Derek W. Bartlett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek W. Bartlett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek W. Bartlett more than expected).

Fields of papers citing papers by Derek W. Bartlett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek W. Bartlett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek W. Bartlett. The network helps show where Derek W. Bartlett may publish in the future.

Co-authorship network of co-authors of Derek W. Bartlett

This figure shows the co-authorship network connecting the top 25 collaborators of Derek W. Bartlett. A scholar is included among the top collaborators of Derek W. Bartlett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek W. Bartlett. Derek W. Bartlett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Graves, Lee M., et al.. (2025). Dose Optimization of ClpP Agonists Using an In Vitro Microfluidic Perfusion Platform and In Silico Pharmacokinetic-Pharmacodynamic Modeling. The AAPS Journal. 27(4). 109–109.

Colburg, Deana R.C., Ophir Vermesh, Anthony Chen, et al.. (2025). Advancing In Vivo Detection of T-Cell Function: Development and Preclinical Evaluation of ⁸⁹Zr-Ivuxolimab, a Human OX40 PET Tracer. Journal of Nuclear Medicine. 66(9). 1449–1457.

Derheimer, Frederick A., Natalie Miller, Casey L. Quinlan, et al.. (2024). Abstract LB028: Discovery and characterization of selective heterobifunctional degraders of EP300 in hematopoietic malignancies. Cancer Research. 84(7_Supplement). LB028–LB028.

O’Brien, Matthew N., Suman Luthra, Matthew F. Brown, & Derek W. Bartlett. (2023). Delivering on the promise of protein degraders. Nature Reviews Drug Discovery. 22(5). 410–427. 60 indexed citations

Bartlett, Derek W. & A. Gilbert. (2022). Translational PK–PD for targeted protein degradation. Chemical Society Reviews. 51(9). 3477–3486. 34 indexed citations

Kindt, Erick, et al.. (2020). A Microfluidic Perfusion Platform for In Vitro Analysis of Drug Pharmacokinetic-Pharmacodynamic (PK-PD) Relationships. The AAPS Journal. 22(2). 53–53. 22 indexed citations

Bartlett, Derek W. & A. Gilbert. (2020). A kinetic proofreading model for bispecific protein degraders. Journal of Pharmacokinetics and Pharmacodynamics. 48(1). 149–163. 24 indexed citations

Bartlett, Derek W., et al.. (2019). Development of an In Vivo Retrodialysis Calibration Method Using Stable Isotope Labeling to Monitor Metabolic Pathways in the Tumor Microenvironment via Microdialysis. Journal of Pharmaceutical Sciences. 108(9). 3124–3129. 2 indexed citations

Bartlett, Derek W., et al.. (2019). Inhibition of immune checkpoints PD-1, CTLA-4, and IDO1 coordinately induces immune-mediated liver injury in mice. PLoS ONE. 14(5). e0217276–e0217276. 40 indexed citations

10.

Bartlett, Derek W., et al.. (2016). A quantitative systems pharmacology (QSP) model to assess the action of blinatumomab in NHL patients (pts).. Journal of Clinical Oncology. 34(15_suppl). e14511–e14511. 3 indexed citations

11.

Ermakov, Sergey, Piers Forster, Albert Wang, et al.. (2014). Virtual Systems Pharmacology (ViSP) software for simulation from mechanistic systems-level models. Frontiers in Pharmacology. 5. 232–232. 9 indexed citations

12.

Sano, Kohei, Takahito Nakajima, Derek W. Bartlett, et al.. (2013). Activatable fluorescent cys-diabody conjugated with indocyanine green derivative: consideration of fluorescent catabolite kinetics on molecular imaging. Journal of Biomedical Optics. 18(10). 101304–101304. 18 indexed citations

13.

Heidel, Jeremy D., Yun Yen, Bingsen Zhou, et al.. (2007). Potent siRNA Inhibitors of Ribonucleotide Reductase Subunit RRM2 Reduce Cell Proliferation In vitro and In vivo. Clinical Cancer Research. 13(7). 2207–2215. 130 indexed citations

14.

Bartlett, Derek W. & Mark E. Davis. (2007). Impact of tumor‐specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA‐containing nanoparticles. Biotechnology and Bioengineering. 99(4). 975–985. 125 indexed citations

15.

Bartlett, Derek W. & Mark E. Davis. (2006). Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA‐mediated gene silencing. Biotechnology and Bioengineering. 97(4). 909–921. 122 indexed citations

16.

Walther, Jason L., et al.. (2006). Downloadable computer models for renal replacement therapy. Kidney International. 69(6). 1056–1063. 21 indexed citations

17.

Bartlett, Derek W.. (2006). Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acids Research. 34(1). 322–333. 446 indexed citations

18.

Bartlett, Derek W. & Mark E. Davis. (2006). 705. A Practical Approach to siRNA-Based Treatment Design Using Bioluminescent Imaging and Mathematical Modeling. Molecular Therapy. 13. S272–S273. 1 indexed citations

19.

Hu‐Lieskovan, Siwen, Jeremy D. Heidel, Derek W. Bartlett, Mark E. Davis, & Timothy J. Triche. (2005). Sequence-Specific Knockdown of EWS-FLI1 by Targeted, Nonviral Delivery of Small Interfering RNA Inhibits Tumor Growth in a Murine Model of Metastatic Ewing's Sarcoma. Cancer Research. 65(19). 8984–8992. 423 indexed citations

20.

Meyer, Timothy W., et al.. (2004). Increasing Dialysate Flow and Dialyzer Mass Transfer Area Coefficient to Increase the Clearance of Protein-bound Solutes. Journal of the American Society of Nephrology. 15(7). 1927–1935. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact